China Biologic Now Included in the NASDAQ Global Select Market
TAI'AN, China, Jan. 4, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, today announced that NASDAQ has notified it that the Company has m...
China Biologic Appoints KPMG as its Independent Registered Public Accounting Firm
TAI'AN, China, Dec. 23, 2010 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO, the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, today announced that it has dismissed Frazer Frost, LLP (Frazer Frost") as the Compa...
China Biologic Starts Plasma Collection at Yishui Station
TAI'AN, China, Dec. 7, 2010 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, operating through its indirect majority-owned subsidiaries, Shandong Taiban...
China Biologic Special Committee Completes Investigation
TAI'AN, China, Dec. 6, 2010 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), operating through its indirect majority-owned subsidiaries, Shando...
China Biologic Products Appoints President
TAI'AN, China, Dec. 6, 2010 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), operating through its indirect majority-owned subsidiaries, Shando...
China Biologic Products Announces Record Third Quarter 2010 Results
- Q3 revenue grew 33.2% to $36.0 million - Non-GAAP adjusted net income grew 48.7% to $10.5 million TAI'AN, China, Nov. 16, 2010 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical compani...
China Biologic Products to Present at Brean Murray, Carret 2010 China Growth Conference
TAI'AN, China, Nov. 15, 2010 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that the Company's management will present at the upcoming Brean Murray, Carret & Co. 2010 C...
China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results
TAI'AN, Shandong, China, Nov. 9, 2010 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will host a conference call at 9:00 a.m. EST on Tuesday, November...
China Biologic Products Announces Record Second Quarter 2010 Results
-- Q2 revenue grew 23.3% to $40.9 million -- Non-GAAP adjusted net income grew 31.2% to $10.9 million TAI'AN, China, Aug. 16 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical comp...
China Biologic Products Schedules Conference Call to Discuss Second Quarter 2010 Results
TAI'AN, China, Aug. 13 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) (the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will host a conference call at 8:00 a.m. Eastern Daylight Time on Monday, August 16, 2010, to discuss its s...
China Biologic Products to Attend Canaccord Genuity 30th Annual Growth Conference
TAI'AN, China, July 29 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), operating through its indirect majority-owned subsidiaries, S...
China Biologic Products to Present at Jeffries 2010 Global Life Sciences Conference
TAI'AN, China, June 8 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will present at the Jeffries 2010 Global Life Sciences Conference, which is b...
China Biologic Products Announces First Quarter 2010 Results
- Q1 revenue grew 28.1% to $27.1 million - Non-GAAP adjusted net income grew 60.6% to $7.5 million TAI'AN, China, May 17 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the...
China Biologic Products Schedules Conference Call to Discuss First Quarter 2010 Results
TAI'AN, China, May 14 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will host a conference call at 8:00 a.m. EDT on Monday, May 17, 2010, to discuss the fi...
China Biologic Products to Build Two New Plasma Stations in Shandong Province
TAI'AN, China, May 12 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that its majority-owned subsidiary, Shandong Taibang Biological Products Co. Ltd. ("Shandong Ta...
China Biologic Products to Receive Government Benefits to Continue R&D Innovation
TAI'AN, China, April 27 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that its majority-owned subsidiary, Shandong Taibang Biological Products Co. Ltd. ("Shandong ...
China Biologic Products Announces Record Fourth Quarter and Full Year 2009 Results
- Full-year revenue grew 154.5% to $119.0 million - Non-GAAP adjusted net income rose 135.0% to $31.3 million, or $1.38 per diluted share TAI'AN, Shandong, China, March 24 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), one o...
China Biologic Products Schedules Conference Call to Discuss Fourth Quarter and Full Year 2009 Results
TAI'AN, China, March 22 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will host a conference call at 9:00 a.m. EDT on Wednesday, March 24, 2010, to discuss...
China Biologic Products to Present at the Rodman & Renshaw Annual China Investment Conference
TAI'AN, China, March 3 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that the Company's management team will present at the Rodman & Renshaw Annual C...
China Biologic Products Retains O'Melveny & Myers LLP to Advise on Special Investigation
TAI'AN, China, March 1 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that the special committee of independent directors appointed by the Company's board of Direct...